Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer
In this case-control study of arterial dissections or aneurysms in patients receiving targeted therapy for mCRC, the lack of association with angiogenesis inhibitor exposure was reassuring, given the established benefits of these drugs, particularly bevacizumab, for this indication.
Authors
- Alexandre Pariente (ORCID: https://orcid.org/0000-0002-7873-5483)
- P. Noize
- Julien Bezin (ORCID: https://orcid.org/0000-0002-2568-1928)
- Xavier Bérard (ORCID: https://orcid.org/0000-0002-5629-2482)
- Allison Singier (ORCID: https://orcid.org/0000-0003-3151-6299)
- Sandy Maumus‐Robert (ORCID: https://orcid.org/0000-0002-3501-335X)
- Emmanuelle Kempf (ORCID: https://orcid.org/0000-0002-9285-1966)
- Abraham Munoz
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Bordeaux Population Health (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.46960
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00